LEADER 01272nam0 22002771i 450 001 UON00093520 005 20231205102521.899 010 $a37-00-12591-7 100 $a20020107d1996 |0itac50 ba 101 $ager 102 $aAT 105 $a|||| ||||| 200 1 $aHanghaus 1 in Ephesos$fClaudia Lang-Auinger 210 $aWien$cVerlag der Osterreichischen Akademie der Wissenschaften$d199 218 p. ; 35 cm + tav. 316 $aLOCALIZZATO N 1 GRANDI FORMATI$5IT-UONSI N 1EPHESOS001/08/3 410 1$1001UON00087438$12001 $aForschungen in Ephesos$v8.3 620 $aAT$dWien$3UONL003140 686 $aN1$cTOPOGRAFIA MEDITERRANEO$2A 700 1$aLANG-AUINGER$bClaudia$3UONV060272$0531971 712 $aÖsterreichische Akademie der Wissenschaften$3UONV248181$4650 801 $aIT$bSOL$c20240220$gRICA 912 $aUON00093520 950 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$dSI N 1 EPHESOS 001 08/3 $eSI MC 20385 7 08/3 LOCALIZZATO N 1 GRANDI FORMATI 950 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$dSI N 1 EPHESOS 001 08/3 TAV - GRANDI FO$eSI MC 26621 7 08/3 TAV - GRANDI FO 996 $aHanghaus 1 in Ephesos$91238868 997 $aUNIOR LEADER 01427nas 22004573 450 001 9910986118203321 005 20250415134338.0 011 $a2831-4433 035 $a(OCoLC)1304260132 035 $a(CKB)5720000000183673 035 $a(CONSER)--2022200468 035 $a(EXLCZ)995720000000183673 100 $a20220318a20239999 --- a 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aPsychedelic medicine 210 1$aNew Rochelle, New York :$cMary Ann Liebert Inc.,$d2023- 215 $a1 online resource 311 08$a2831-4425 531 0 $aPsychedelic med. 606 $aHallucinogenic drugs$xTherapeutic use 606 $aMental illness$xTreatment 606 $aPsychotherapy 606 $aHallucinogenic drugs$xTherapeutic use$2fast$3(OCoLC)fst00950658 606 $aMental illness$xTreatment$2fast$3(OCoLC)fst01016606 606 $aPsychotherapy$2fast$3(OCoLC)fst01081755 615 0$aHallucinogenic drugs$xTherapeutic use. 615 0$aMental illness$xTreatment. 615 0$aPsychotherapy. 615 7$aHallucinogenic drugs$xTherapeutic use. 615 7$aMental illness$xTreatment. 615 7$aPsychotherapy. 676 $a615 712 02$aMary Ann Liebert, Inc., 906 $aJOURNAL 912 $a9910986118203321 996 $aPsychedelic medicine$94328668 997 $aUNINA